HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 7,237-7,248 of 27,277
Device study icon
CompletedNCT04542642

A Remote, Decentralized Addiction Study to Evaluate Patient Engagement With a Game-Based Digital Therapeutic

Official study title

A Randomized, Controlled, Open-Label, Decentralized Study, to Evaluate Patient Engagement With PEAR-008, a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including New York
AddictionDevice studyAges 18–60
Countries
United States
Sponsor
Pear Therapeutics, Inc.
Drug study icon
CompletedNCT01209039

A Repeat Dose Positron Emission Tomography Study With GSK1144814

Official study title

A Healthy Volunteer Repeat Dose Study to Evaluate; the Safety, Tolerability, Pharmacokinetics, Effects on the Pharmacokinetics of Midazolam and the Neurokinin 1 Receptor Occupancy of GSK1144814

This study has finished and is no longer accepting participants.

Multiple locations, including Harrow
SchizophreniaMedication studyAges 18–65
Countries
United Kingdom
Sponsor
GlaxoSmithKline
Drug study icon
TerminatedNCT00929370

A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and people with Schizophrenia and to Evaluate Its Effect on PK of Midazolam.

Official study title

A 4-Part Parallel Group, Randomized, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Repeat Doses of GSK1018921 in Healthy Volunteers and Stable Patients With Schizophrenia and to Evaluate Its Effects on Pharmacokinetics of Midazolam.

This study ended early.

Multiple locations, including Glendale
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
GlaxoSmithKline
Other study type icon
CompletedACTRN12618000886280

A resilience program for adolescents in organised sport

Official study title

Examining the effects of an internet-supported resilience intervention for adolescents in organised sport

This study has finished and is no longer accepting participants.

In Australia
Mental healthInterventional studyAges 12–18
Countries
Australia
Sponsor
Dr Christian Swann
Other study type icon
CompletedNCT01607593

Sertraline for PTSD

Official study title

A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients

This study has finished and is no longer accepting participants.

Multiple locations, including Kurume
PTSDObservational studyAges 18+
Countries
Japan
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Other study type icon
CompletedNCT01214135

Use of Seroquel Extended Release (XR) and Immediate Release (IR) for schizophrenia

Official study title

A Retrospective, Non-interventional Study to Evaluate the Use of Seroquel XR and Seroquel IR in the Clinical Practice of Inpatients With Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Falköping
SchizophreniaObservational studyAges 18–65
Countries
Sweden
Sponsor
AstraZeneca

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.